BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31199317)

  • 21. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations.
    van Pelt GW; Kjær-Frifeldt S; van Krieken JHJM; Al Dieri R; Morreau H; Tollenaar RAEM; Sørensen FB; Mesker WE
    Virchows Arch; 2018 Oct; 473(4):405-412. PubMed ID: 30030621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact.
    van Pelt GW; Sandberg TP; Morreau H; Gelderblom H; van Krieken JHJM; Tollenaar RAEM; Mesker WE
    Histopathology; 2018 Aug; 73(2):197-206. PubMed ID: 29457843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study.
    Scheer R; Baidoshvili A; Zoidze S; Elferink MAG; Berkel AEM; Klaase JM; van Diest PJ
    World J Gastrointest Oncol; 2017 Dec; 9(12):466-474. PubMed ID: 29290917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A computed tomography-based multitask deep learning model for predicting tumour stroma ratio and treatment outcomes in patients with colorectal cancer: a multicentre cohort study.
    Cui Y; Zhao K; Meng X; Mao Y; Han C; Shi Z; Yang X; Tong T; Wu L; Liu Z
    Int J Surg; 2024 May; 110(5):2845-2854. PubMed ID: 38348900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system.
    Peng C; Liu J; Yang G; Li Y
    J Gastroenterol; 2018 May; 53(5):606-617. PubMed ID: 28815347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
    Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
    Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of tumor-stromal ratio combined with TNM staging system in esophagus squamous cell carcinoma.
    He R; Li D; Liu B; Rao J; Meng H; Lin W; Fan T; Hao B; Zhang L; Lu Z; Feng H; Zhang Z; Yuan J; Geng Q
    J Cancer; 2021; 12(4):1105-1114. PubMed ID: 33442408
    [No Abstract]   [Full Text] [Related]  

  • 31. The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.
    Vangangelt KMH; Tollenaar LSA; van Pelt GW; de Kruijf EM; Dekker TJA; Kuppen PJK; Tollenaar RAEM; Mesker WE
    Int J Cancer; 2018 Dec; 143(12):3194-3200. PubMed ID: 29978463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stromal organization as predictive biomarker for the treatment of colon cancer with adjuvant bevacizumab; a post-hoc analysis of the AVANT trial.
    Zunder S; van der Wilk P; Gelderblom H; Dekker T; Mancao C; Kiialainen A; Putter H; Tollenaar R; Mesker W
    Cell Oncol (Dordr); 2019 Oct; 42(5):717-725. PubMed ID: 31102145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer.
    Geessink OGF; Baidoshvili A; Klaase JM; Ehteshami Bejnordi B; Litjens GJS; van Pelt GW; Mesker WE; Nagtegaal ID; Ciompi F; van der Laak JAWM
    Cell Oncol (Dordr); 2019 Jun; 42(3):331-341. PubMed ID: 30825182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-Stroma Ratio in ER+/HER2- Breast Cancer: Is it a Tool for Treatment Decision?
    Elmhadi C; Allaoui M; Zerrik M; Oukabli M; Tanz R; Ichou M
    Gulf J Oncolog; 2023 May; 1(42):14-21. PubMed ID: 37283255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival.
    Xi KX; Wen YS; Zhu CM; Yu XY; Qin RQ; Zhang XW; Lin YB; Rong TH; Wang WD; Chen YQ; Zhang LJ
    J Thorac Dis; 2017 Oct; 9(10):4017-4026. PubMed ID: 29268412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigating the role of core needle biopsy in evaluating tumor-stroma ratio (TSR) of invasive breast cancer: a retrospective study.
    Le MK; Odate T; Kawai M; Oishi N; Kondo T
    Breast Cancer Res Treat; 2023 Jan; 197(1):113-121. PubMed ID: 36335529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computerized Assessment of the Tumor-stromal Ratio and Proposal of a Novel Nomogram for Predicting Survival in Invasive Breast Cancer.
    Qian X; Xiao F; Chen YY; Yuan JP; Liu XH; Wang LW; Xiong B
    J Cancer; 2021; 12(12):3427-3438. PubMed ID: 33995621
    [No Abstract]   [Full Text] [Related]  

  • 38. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
    Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
    Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer.
    Chen Y; Zhang L; Liu W; Liu X
    Biomed Res Int; 2015; 2015():589301. PubMed ID: 26609529
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.